USX:MBRX - Moleculin Biotech, Inc Moleculin Biotech, Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 10 Aug 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 3.6    -0.080 (-2.17%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

21 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Walter V. Klemp

IPO: 2016-06-02

Headquarters: US

Employees: 10

Homepage

Description

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with its focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.